SCHEMBL12606391

SCHEMBL12606391

COC1C(OC)[C@H](O[C@H]2O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]3OC(C(=O)O)[C@@H](O[C@H]4OC(COS(=O)(=O)O)[C@@H](OC)[C@H](OC)C4C)[C@H](OC)C3OC)C(OSOOO)C2OSOOO)[C@H](C(=O)O)O[C@H]1O[C@@H]1C(COS(=O)(=O)O)O[C@H](OC)C(OSOOO)[C@H]1OSOOO

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SERPINC1 P01008 3/20 0.58
▸ F10 P00742 6/20 0.44
▸ FGF1 P05230 4/20 0.43
▸ F2 P00734 1/20 0.41
▸ HPSE Q9Y251 5/20 0.36
▸ FGF2 P09038 1/20 0.33
▸ BDNF P23560 2/20 0.31
▸ PTN P21246 1/20 0.31
▸ MDK P21741 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606393 0.91 SERPINC1 (0.60) SERPINC1F10FGF1F2HPSE
SCHEMBL12606386 0.88 SERPINC1 (0.54) SERPINC1F10FGF1F2HPSE
SCHEMBL12606421 0.86 SERPINC1 (0.53) SERPINC1F10FGF1F2HPSE
SCHEMBL12606383 0.85 SERPINC1 (0.51) SERPINC1F10FGF1F2HPSE
SCHEMBL14363911 0.84 SERPINC1 (0.57) SERPINC1F10FGF1F2HPSE
SCHEMBL13039102 0.84 SERPINC1 (0.57) SERPINC1F10FGF1F2HPSE
SCHEMBL13039108 0.83 SERPINC1 (0.54) SERPINC1F10FGF1F2HPSE
SCHEMBL14363912 0.81 SERPINC1 (0.51) SERPINC1F10FGF1F2HPSE
SCHEMBL13039103 0.81 SERPINC1 (0.51) SERPINC1F10FGF1F2HPSE
SCHEMBL14363878 0.81 SERPINC1 (0.52) SERPINC1F10FGF1F2HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943595-B2 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative SANOFI-AVENTIS (FR) 2011-05-17 — — US disclosed
Send feedback